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The study of rapid changes in brain dynamics and functional connectivity (FC) is
of increasing interest in neuroimaging. Brain states departing from normal waking
consciousness are expected to be accompanied by alterations in the aforementioned
dynamics. In particular, the psychedelic experience produced by psilocybin (a sub-
stance found in “magic mushrooms”) is characterized by unconstrained cognition and
profound alterations in the perception of time, space and selfhood. Considering the
spontaneous and subjective manifestation of these effects, we hypothesize that neural
correlates of the psychedelic experience can be found in the dynamics and variability
of spontaneous brain activity fluctuations and connectivity, measurable with func-
tional Magnetic Resonance Imaging (fMRI). Fifteen healthy subjects were scanned
before, during and after intravenous infusion of psilocybin and an inert placebo.
Blood-Oxygen Level Dependent (BOLD) temporal variability was assessed comput-
ing the variance and total spectral power, resulting in increased signal variability
bilaterally in the hippocampi and anterior cingulate cortex. Changes in BOLD signal
spectral behavior (including spectral scaling exponents) affected exclusively higher
brain systems such as the default mode, executive control and dorsal attention net-
works. A novel framework enabled us to track different connectivity states explored
by the brain during rest. This approach revealed a wider repertoire of connectivity
states post-psilocybin than during control conditions. Together, the present results
provide a comprehensive account of the effects of psilocybin on dynamical behaviour
in the human brain at a macroscopic level and may have implications for our un-
derstanding of the unconstrained, hyper-associative quality of consciousness in the
psychedelic state.
Keywords : Psilocybin, fMRI, functional connectivity, resting state, psychedelic
state
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I. INTRODUCTION
Psilocybin (phophoryl-4-hydroxy-dimethyltryptamine) is the phosphorylated ester of the
main psychoactive compound found in magic mushrooms. Pharmacologically related to the
prototypical psychedelic LSD, psilocybin has a long history of ceremonial use via mush-
room ingestion and, in modern times, psychedelics have been assessed as tools to enhance
the psychotherapeutic process (Grob et al., 2011; Krebs et al., 2012; Moreno et al., 2006).
The subjective effects of psychedelics include (but are not limited to) unconstrained, hyper-
associative cognition, distorted sensory perception (including synesthesia and visions of dy-
namic geometric patterns) and alterations in one’s sense of self, time and space. There is
recent preliminary evidence that psychedelics may be effective in the treatment of anxi-
ety related to dying (Grob et al., 2011) and obsessive compulsive disorder (Moreno et al.,
2006) and there are neurobiological reasons to consider their potential as antidepressants
(Carhart-Harris et al., 2012a,b). Similar to ketamine (another novel candidate antidepres-
sant) psychedelics may also mimic certain psychotic states such as the altered quality of
consciousness that is sometimes seen in the onset-phase of a first psychotic episode (Carhart-
Harris et al., 2014). There is also evidence to consider similarities between the psychology
and neurobiology of the psychedelic state and Rapid Eye Movement (REM) sleep (Carhart-
Harris, 2007; Carhart-Harris & Nutt, 2014), the sleep stage associated with vivid dreaming
(Aserinsky and Kleitman, 1953)
The potential therapeutic use of psychedelics, as well as their capacity to modulate the
quality of conscious experience in a relatively unique and profound manner, emphasizes the
importance of studying these drugs and how they act on the brain to produce their novel
effects. One potentially powerful way to approach this problem is to exploit human neu-
roimaging to measure changes in brain activity during the induction of the psychedelic state.
The neural correlates of the psychedelic experience induced by psilocybin have been recently
assessed using Arterial Spin Labeling (ASL) and BOLD fMRI (Carhart-Harris et al., 2012a).
This work found that psilocybin results in a reduction of both CBF and BOLD signal in ma-
jor subcortical and cortical hub structures such as the thalamus, posterior cingulate (PCC)
and medial prefrontal cortex (mPFC) and in decreased resting state functional connectivity
(RSFC) between the normally highly coupled mPFC and PCC. Furthermore, our most re-
cent study used magnetoencephalography (MEG) to more directly measure altered neural
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activity post-psilocybin and here we found decreased oscillatory power in the same cortical
hub structures (Muthukumaraswamy et al., 2013, see also Carhart-Harris et al. 2014 for a
review on this work).
These results establish that psilocybin markedly affects BOLD, CBF, RSFC and oscilla-
tory electrophysiological measures in strategically important brain structures, presumably
involved in information integration and routing (Hagmann et al., 2008; Leech et al., 2012;
de Pasquale et al., 2012; Carhart-Harris et al. 2014). However, the effects of psilocybin
on the variance of brain activity parameters across time has been relatively understudied
and this line of enquiry may be particularly informative in terms of shedding new light on
the mechanisms by which psychedelics elicit their characteristic psychological effects. Thus,
the main objective of this paper is to examine how psilocybin modulates the dynamics and
temporal variability of resting state BOLD activity.
Once regarded as physiological noise, a large body of research has now established that
resting state fluctuations in brain activity have enormous neurophysiological and functional
relevance (Fox and Raichle, 2007). Spontaneous fluctuations self-organize into internally
coherent spatio-temporal patterns of activity that reflect neural systems engaged during
distinct cognitive states (termed “intrinsic” or “resting state networks” - RSNs) (Fox and
Raichle, 2005; Raichle, 2011; Smith et al., 2009). It has been suggested that the variety of
spontaneous activity patterns that the brain enters during task-free conditions reflects the
naturally itinerant and variegated quality of normal consciousness (Raichle, 2011). However,
spatio-temporal patterns of resting state activity are globally well preserved in states such as
sleep (Larson-Prior et al., 2009; Boly et al., 2009, 2012; Brodbeck et al., 2012; Tagliazucchi et
al., 2013a,b,c) in which there is a reduced level of awareness – although very specific changes
in connectivity occur across NREM sleep, allowing the decoding of the sleep stage from
fMRI data (Tagliazucchi et al., 2012c; Tagliazucchi & Laufs, 2014). Thus, if the subjective
quality of consciousness is markedly different in deep sleep relative to the normal wakeful
state (for example) yet FC measures remain largely preserved, this would suggest that these
measures provide limited information about the biological mechanisms underlying different
conscious states. Similarly, intra-RSN FC is decreased under psilocybin (Carhart-Harris et
al., 2012b) yet subjective reports of unconstrained or even “expanded” consciousness are
common among users (see Carhart-Harris et al. 2014 for a discussion). Thus, the present
analyses are motivated by the view that more sensitive and specific indices are required to
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develop our understanding of the neurobiology of conscious states, and that measures which
factor in variance over time may be particularly informative.
A key feature of spontaneous brain activity is its dynamical nature. In analogy to other
self-organized systems in nature, the brain has been described as a system residing in (or at
least near to) a critical point or transition zone between states of order and disorder (Chialvo,
2010; Tagliazucchi & Chialvo, 2011; Tagliazucchi et al., 2012a; Haimovici et al., 2013). In
this critical zone, it is hypothesized that the brain can explore a maximal repertoire of its
possible dynamical states, a feature which could confer obvious evolutionary advantages in
terms of cognitive and behavioral flexibility. It has even been proposed that this cognitive
flexibility and range may be a key property of adult human consciousness itself (Tononi,
2012). An interesting research question therefore is whether changes in spontaneous brain
activity produced by psilocybin are consistent with a displacement from this critical point
- perhaps towards a more entropic or super-critical state (i.e. one closer to the extreme of
disorder than normal waking consciousness) (Carhart-Harris et al. 2014). Further motivat-
ing this hypothesis are subjective reports of hyper-associative cognition under psychedelics,
indicative of unconstrained brain dynamics. Thus, in order to test this hypothesis, it makes
conceptual sense to focus on variability in activity and FC parameters over time, instead of
the default procedure of averaging these over a prolonged period.
In what follows, we present empirical data that tests the hypothesis that brain activity
becomes less ordered in the psychedelic state and that the repertoire of possible states is
enhanced. After the relevant findings have been presented, we engage in a discussion to sug-
gest possible strategies that may further characterize quantitatively where the “psychedelic
brain” resides in state space relative to the dynamical position occupied by normal waking
consciousness.
II. MATERIALS AND METHODS
Study overview and design
This was a within-subjects placebo-controlled study. The study was approved by a lo-
cal NHS Research Ethics Committee and University of Bristol Research and Development
department, and conducted in accordance with Good Clinical Practice guidelines. A Home
Office License was obtained for storage and handling of a Schedule 1 drug and the University
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of Bristol sponsored the research.
Participants
This is a new analysis on previously published data (Carhart-Harris et al., 2012a,b).
Fifteen healthy subjects took part: 13 males and 2 females (mean age = 32, SD = 8.9).
Recruitment was via word of mouth. All subjects were required to give informed consent and
undergo health screens prior to enrollment. Study inclusion criteria were: at least 21 years
of age, no personal or immediate family history of a major psychiatric disorder, substance
dependence, cardiovascular disease, and no history of a significant adverse response to a
hallucinogenic drug. All of the subjects had used psilocybin at least once before (mean
number of uses per subject = 16.4, SD = 27.2) but not within 6 weeks of the study.
Anatomical Scans
Image acquisition was performed on a 3T GE HDx system. Anatomical scans were
performed before each functional scan and thus during sobriety. These were 3D fast spoiled
gradient echo scans in an axial orientation, with field of view = 256×256×192 and matrix =
256×256×192 to yield 1 mm isotropic voxel resolution (repetition time/echo time [TR/TE]
= 7.9/3.0 ms; inversion time = 450 ms; flip angle = 20).
Drug infusion
All subjects underwent two 12 min eyes closed resting state BOLD fMRI scans on 2
separate occasions at least 7 days apart: placebo (10 ml saline, 60 s intravenous injection)
was given on one occasion and psilocybin (2 mg dissolved in 10 ml saline, 60 s infusion) on
the other. Seven of the subjects received psilocybin in scan 1, and 8 received it in scan 2.
Injections were given manually by a doctor within the scanning suite. The 60 s infusions
began exactly 6 min after the start of the 12 min scans. The subjective effects of psilocybin
were felt almost immediately after injection and were sustained for the remainder of the RS
scan. For more details on the subjective effects of intravenous psilocybin see (Carhart-Harris
et al., 2012a,b)
fMRI Data acquisition and pre-processing
BOLD-weighted fMRI data were acquired using a gradient echo planar imaging sequence,
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TR/TE 3000/35 ms, field-of-view = 192 mm, 64 × 64 acquisition matrix, parallel accelera-
tion factor = 2, 90 flip angle. Fifty-three oblique axial slices were acquired in an interleaved
fashion, each 3 mm thick with zero slice gap (3 × 3 × 3 mm voxels). A total of 240 volumes
were acquired, with infusion taking place in the middle of the session. Data were motion
corrected using FSL MCFLIRT and a high-pass filter of 100 s was applied. Data were
smoothed using a Gaussian kernel of 5 mm FWHM. Motion time courses were regressed
from the data during the pre-processing step, together with average CSF and white matter
time courses. As an additional control to exclude epochs of large movement amplitude, all
volumes associated with a mean head displacement larger than 1 s.d. were erased from the
analysis.
Analysis of spatio-temporal dynamics
The methods here employed are based on a statistical physics framework useful for char-
acterizing fluctuations in systems composed of large number of coupled degrees of freedom.
From this perspective, fluctuating activity in a particular region and correlations between
different regions are interdependent or related (Ross, 1966). Therefore, any change in the
cortical dynamics due to a given intervention is expected to be reflected both at the level
of the variance of the activity at one region and in the strength of the interactions between
different regions. In what follows, the methodology accounting for these two aspects (i.e.
the temporal variability and the dynamical changes in correlations) are explained in detail.
All the numerical analyses for these calculations were performed using in-house MATLAB
scripts.
Analysis of temporal variability
The analysis referred to here as “temporal variability” is concerned with the variance
in the amplitude of the BOLD signal and it can be expressed both in a temporal (i.e., the
standard variance) and frequency domain, as will be explained below. As a time domain
measure of variability in the amplitude of the BOLD signal, straightforward voxel-wise
computation of BOLD variance was performed, resulting in whole-brain BOLD variance
maps for each condition (psilocybin/placebo before and after infusion) and participant. An
additional evaluation of variance can be performed in the frequency domain, noting that by
Parseval’s theorem:
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∫
x2(t)dt =
∫
|A(f)|2df (1)
Then, the following series of equalities holds (for a signal with zero mean):
σ2 = lim
T→∞
1
T
∫ T/2
−T/2
x2(t)dt = lim
T→∞
1
T
∫
|A(f)|2df =
∫
Φ(f)df (2)
In Eqs. 1 and 2, A(f) represents the Fourier transform of x(t) and Φ(f) is the power
spectral density. Therefore, the variance can also be obtained by integrating Φ(f) across the
whole range of frequencies.
Further spectral analysis of BOLD fluctuations
Eqs. 1 and 2 show that the integral of the power spectral density equals the variance of
the signal. If this integral is not performed across all frequencies but in a certain range, the
result will correspond to the contribution of the frequencies to the variance in the specified
ranges. It is generally considered that slow (0.01 - 0.1 Hz) BOLD frequencies carry neural
significance in the resting state fMRI signal (Cordes et al., 2001), therefore, we evaluated
separately the low frequency power (LFP) in this range and compared it before and after
the psilocybin infusion.
Given the fact that the spectral content of spontaneous BOLD fluctuations, like many
other complex systems in nature, follows a power law of the form 1
fα
(Expert et al., 2011), its
power spectrum density can also be characterized by a single parameter (α). This parameter
condenses the scaling behavior and is demonstrative of the long-range temporal correlations
(or memory) of any given signal. Thus, for uncorrelated noise, α = 0 (i.e. a flat spectrum, or
so called “white noise”) is obtained, whereas for signals presenting some degree of long-term
correlations, values of α > 0 (i.e., the so called “colored noise”) are observed. To obtain the
scaling exponent α, the first derivative of BOLD time series was first computed (in order to
minimize the influence of non-stationarities) and the fit was performed on the spectrum of
the derivative. Note that for a power spectrum of the form 1
fα
, differentiation decreases the
value of by 2, so the exponent of the original time series can be recovered from that of the
derivative.
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Point-process analysis
A recent series of studies demonstrated that the continuous BOLD signal can be trans-
formed into a discrete point-process encoding the timings of the most functionally relevant
events (Tagliazucchi et al., 2010a,b, 2012a; Petridou et al., 2012, Davis et al., 2013). In
this approach, relevant events are defined by a threshold crossing (e.g. whenever the signal
departs +1 s.d. from its mean value). Besides allowing a dramatic compression of the infor-
mation present in a BOLD timeseries, this approach has the particular benefit of allowing a
simple criterion to eliminate motion artifacts: i.e. “points” (threshold crossings) occurring
during high movement epochs (i.e. larger than a certain value) are simply ignored in the
analysis.
Two interdependent observables are defined once the point-process is obtained: the rate
(number of crossings divided by the series length) and inter-event intervals (average temporal
separation between two consecutive points). On average, there is a clear inverse relationship
between these two variables. Furthermore, the rate is expected to increase (or the interval
to decrease) for a signal with a high contribution of fast frequencies.
As an efficient alternative to the spectral analysis described in the previous section, we
computed the voxel-wise distribution of rates and intervals and compared it between the
different conditions.
Computation of dynamical functional connectivity states and its associated
entropy
As already discussed above, for spatio-temporal fluctuations arising from the dynamics
of large scale systems, the relation between the temporal fluctuations of the average signal
and its spatial correlation function is well defined (Ross, 1966). It is known that under
general assumptions, the mean field peak-to-peak amplitude of a signal (or its variance)
is directly proportional to its mean correlation value. Intuitively, this is analogous to the
principle that synchronized/desynchronized clapping produces stronger/weaker collective
effects. Therefore, to complement the investigation of regional changes in the variance of the
BOLD signal in various regions of the cortex, it is logical to also look at measures of the mean
functional correlations between participating regions. Given the highly transient nature of
these correlations, we term these indices “dynamical functional connectivity states”. They
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are computed as follows (see Fig. 4 for an illustration of the general procedure).
The BOLD time series is first divided into M non-overlapping windows of length L. Then,
the partial correlation values between a set of N brain regions of interest is computed inside
each temporal window as follows,
RC(X, Y ) = minR(X, Y |Z) (3)
where R(X, Y |Z) is defined as follows,
R(X, Y |Z) = R(X, Y )−R(Y, Z)√
1−R(X,Z)2 (4)
In Eq. 3, the minimum is taken across all signals Z different from X,Y. In Eq. 4, R(X,Y)
represents the linear correlation between variables X and Y. Thus, the partial correlation
RC(X, Y ) measures the correlation of both variables removing the effect of a set of controlling
variables. In what follows, the set of variables will include all BOLD signals from the N
brain regions under study plus the time series of absolute head displacement (to remove
spurious correlations), as estimated during the motion correction step. Finally, for each pair
of regions a link is established between them if the correlation p-value is significant at the
level of p < 0.05, Bonferroni corrected (N(N − 1)/2). Performing this computation for all
temporal windows gives the temporal evolution of the connectivity graph.
For N brain regions, the total number of dynamical functional connectivity graphs (i.e.
all possible connectivity motifs) equals 2(N(N−1)/2). For example, for N = 3, 4, 5, the number
of states is 8, 64, 1024. Once the dynamical functional connectivity states are obtained by
the procedure above described, a symbolization procedure can be used to map the limited
amount of states into discrete symbols (a bijection or one-to-one mapping of each temporal
sequence of states into “words” - whose letters represent the different connectivity graphs).
Then, the entropy of this sequence can be computed using the straightforward definition of
Shannon’s entropy:
H =
N(N−1)/2∑
i=1
pi log(1/pi) (5)
where pi is the probability of the i-th state occurring in the sequence.
We evaluate the entropy of dynamical functional connectivity states in the network of
regions of peak statistical significance presented in Table 1 and Fig. 1 (i.e., the left and right
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hippocampus and ACC). This choice is motivated by the well-known observation that, for a
system of coupled elements, the temporal variability of the activity time series is driven by
variability in the collective interactions (Ross, 1966). This process resulted in 4 regions and
a total of 64 connectivity states (i.e. the number of possible dynamical interaction motifs
between the 4 nodes).
Statistical testing
To perform statistical significance testing, a paired t-test was used, as implemented in
SPM8. Only clusters passing a threshold of p < 0.05 Family Wise Error (FWE) corrected for
multiple comparisons were considered significant. For display purposes, significance maps
were thresholded at p < 0.005, showing only clusters passing the above mentioned criterion.
Significance testing for the entropy differences reported in Fig. 5 was also evaluated using a
paired t-test.
III. RESULTS
The statistical significance maps for the BOLD signal variance and total spectral power
can be found in Fig. 1A and the significance peaks are summarized in Table 1 (in this and
the following sections, unless explicitly stated no differences were found by examining the
opposite contrasts). Both measures show increased variability following psilocybin admin-
istration - both in the temporal and spectral domain - with peaks in the anterior cingulate
cortex and bilateral hippocampus (total spectral power is also increased in the bilateral
parahippocampal gyri). As shown in Fig. 1 there is a large overlap in the regions affected
by both measures, as can be expected from Eq. 2. The differences found for the power
spectral estimation in the parahippocampal gyrus are not apparent for the variance. Most
likely this discrepancy is due to the numerical evaluation of these two equivalent quantities.
To find the temporal evolution of the variance increases, we selected the four significance
peaks for BOLD variance as ROIs (Table 1) and used a sliding window analysis (1 min.
window length) to compute the evolution of the variance. Since these ROI are selected as
regions of high variance, it is already known that fluctuations in their activity will have an
increased variance relative to baseline. However, this analysis provides additional informa-
tion about when those increases occurred (e.g. just after the psilocybin infusion or later). In
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Fig. 1B the results of this analysis are presented. A homogeneous increase in signal variance
is observed during the first 3 minutes post-psilocybin infusion, with a tendency to plateau
or slightly decrease afterwards. A longer experiment would be needed to confirm the persis-
tence of this effect, but it does seem to correspond well with the known pharmaco-dynamics
of intravenous psilocybin, i.e. subjects reported the most intense subjective effects within
the first 3 minutes of the infusion and the effects were persistent for the duration of the scan
(Carhart-Harris et al., 2012a,b).
We also studied the variance of intra-hippocampal connectivity time courses, computed
as the linear correlation of all hippocampal voxels over non-overlapping windows of different
lengths. Results are shown in Fig. 1C. It can be seen that the variance is higher in both
hippocampi after the psilocybin infusion.
Next, we studied the spectral content of spontaneous BOLD fluctuations. This was
done by computing the low frequency (0.01-0.1 Hz) power (LFP) and the power spectrum
scaling exponent (α). Statistical significance maps are presented in Fig. 2A and statistical
significance peaks in Table 2.
After psilocybin infusion, diffuse widespread decreases in LFP and the scaling exponent
α were observed in frontal and parietal regions. Changes in LFP and the scaling exponent
(α) were found consistently in the same spatial locations, which is expected since a scaling
closer to that of uncorrelated noise (i.e. an α value closer to 0) will result in weaker low
frequency spectral power. These effects were confined to the post-psilocybin period. No
differences were found when performing the same comparison in the placebo condition.
To further characterize BOLD fluctuations, we transformed whole brain signals into a
spatio-temporal point-process and extracted two statistics: the rate (average number of
events) and the interval (average separation between two events). By the very definition
of the point-process, a signal with high power in fast frequencies will give a high rate and
therefore a low separation between events i.e., the average interval will be small. Results
shown in Fig. 2B confirm this observation. Statistical significance peaks are presented in
Table 3. A rate increase and interval decrease after psilocybin was observed in parietal and
frontal regions largely overlapping with those of Fig. 2A. No differences were found when
performing the same comparison in the placebo condition.
To identify the brain networks associated with the changes shown in Figs. 2A and 2B,
we computed the overlap of the statistical significance maps with a set of well-established
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Resting State Networks (RSNs) (Beckmann and Smith, 2004; Beckmann et al., 2005). These
included: two visual (medial and lateral), an auditory, sensori-motor, default mode, execu-
tive control and two lateralized dorsal attention networks.
To compute the overlap for a given map, we counted the number of voxels included in each
RSN and normalized by the total number of voxels in the RSN mask. Using this approach,
larger maps present a higher chance of having large overlaps, therefore, we constructed a
null-hypothesis by randomizing the phases of the maps (after transforming to Fourier space),
resulting in images with the same second order statistics (see also Tagliazucchi et al., 2013c).
A total of 100 randomizations were performed for each comparison and an empirical p-value
was constructed, counting the ratio of instances in which the real overlap exceeded the
overlap computed with the randomized map. The results of these analyses are presented in
Fig. 3. For LFP and α, significant overlaps were detected in the default mode, control and
attention networks, whereas all sensory networks remained unaffected. For the point-process
rate (PPR) and point-process interval (PPI) the changes were locally confined to the default
mode network.
Next, the dynamic functional connectivity states were obtained from the set of regions
showing increased temporal variability (Fig. 1 and Table 1) by applying the analysis outlined
in Fig. 4. Using different window lengths (ranging from 15 to 150 s.) we evaluated the
entropy of the distribution of connectivity states in the network comprised by two ACC
ROIs and the bilateral hippocampi. An entropy increase was found when comparing the
results between the periods before and after the psilocybin infusion and after the psilocybin
infusion vs. after the placebo infusion, but no changes were observed when comparing before
and after placebo (see Fig. 5A). The entropy increase was not seen for very short window
lengths but was manifest for all lengths larger than approximately 1 min.
The most frequent states in each condition are shown in Fig. 5B. These have sparse
connectivity and represent functional connections between homologous ROIs and between
ROIs in the same hemisphere, but cross-hemisphere connections between hippocampal and
ACC ROIs also appear in the psilocybin condition. The psilocybin state is also characterized
by a larger repertoire of states: i.e. novel motifs that are exclusive to the psychedelic
state and which are shown in the last row of Fig. 5B. These motifs are among the most
interconnected states possible.
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IV. DISCUSSION
The novel analyses described in this paper provide a considerable amount of new infor-
mation about how psilocybin affects brain activity. In summary, increased variance in the
BOLD signal was observed in the bilateral hippocampi and ACC and the temporal dynamics
of these increases corresponded well with the rapid pharmacodynamics of intravenous psilo-
cybin (Carhart-Harris et al., 2012a,b). Decreased low frequency power and frequency scaling
exponent (indicative of a less correlated signal) were observed in higher-level association re-
gions accompanied by an increase in the point process rate at the default mode network.
Perhaps the most novel and intriguing aspect of the present analyses was our assessment of
dynamical functional connectivity within a simple hippocampal/ACC network. Specifically,
a greater diversity of connectivity motifs was observed after psilocybin, reflecting increased
entropy in this system’s dynamical behavior. Overall these quantities demonstrate an in-
crease in the dynamical repertoire (i.e., new states) in the brain under psilocybin as well as
an increase in the rate at which the repertoire is examined.
We first interpret the changes described in the results section from a purely dynamical
point of view. The results presented in Fig. 1 represent a larger variance in the “mean
field activity” of the hippocampus and ACC. This change in variance is the expression of
an increased amplitude of the BOLD signal fluctuations in these regions. From a statistical
physics point of view, increased signal amplitude implies increased synchronization and so
increased correlated activity in the source structures. This is also reflected in the analysis
of the repertoire of connectivity states in a hippocampal-ACC network (discussed in Figs. 4
and 5). These two results together reveal an increased variability in the collective repertoire
(i.e. a larger number of motifs) of metastable states (Tognoli & Kelso, 2014) within the
psychedelic state.
The increased amplitude fluctuations in the hippocampus are particularly intriguing given
early depth electroencephalography (EEG) work that recorded similar abnormalities in hip-
pocampal activity after LSD and mescaline (Schwarz et al., 1956; Monroe and Heath, 1961).
Similar increases in oscillation amplitude have also been observed in the hippocampus us-
ing depth EEG recordings in patients showing nondrug-induced psychotic symptoms (Sem-
Jacobsen et al., 1956; Heath, 1954) and bursts of high amplitude activity have been seen
in human rapid-eye movement (REM) sleep (Cantero et al., 2003). Moreover, other imag-
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ing modalities have implicated increased hippocampal activity in psychosis (e.g., Friston
et al., 1992) and REM sleep (Braun et al., 1997; Miyauchi et al., 2009). Given that phe-
nomenological similarities have previously been noted between the psychedelic, psychotic
and dream states (Carhart-Harris, 2007; Carhart-Harris & Nutt, 2014), it is intriguing to
consider whether altered hippocampal activity may be an important common property of
these states.
It has long been claimed that the psychedelic (translated “mind-revealing” (Huxley et al.,
1977)) state is an expanded state of consciousness in which latent psychological material can
emerge into consciousness (Cohen, 1967) and novel associations can form. Indeed, this was
the original rationale for the use of LSD in psychotherapy (Busch and Johnson, 1950). It has
also been claimed that psychedelics may be able to assist the creative process, for example, by
promoting divergent thinking and remote association (Fadiman, 2011). Thus, the increased
repertoire of metastable states observed here with psilocybin may be a mechanism by which
these phenomena occur (see also Carhart-Harris et al. 2014)
It was also interesting that under psilocybin, more interhemispheric dynamical correla-
tions were detected in the hippocampal/ACC network (Fig 5C). Recent electrophysiological
work in mice has shown that layer 5 pyramidal neurons (the primary cellular units implicated
in the action of psychedelic drugs (Muthukumaraswamy et al., 2013)) that are sensitive to
serotonin 2A receptor mediated excitation (the primary pharmacological process implicated
in the action of psychedelics (Muthukumaraswamy et al., 2013)) are disproportionately those
pyramidal neurons that project interhemispherically (Avesar and Gulledge, 2012). Thus, al-
tered interhemispheric communication may be an important component of the mechanism
of action of psychedelics.
Concerning the low frequency fluctuations results, these were consistent with our ear-
lier work with MEG in which we observed decreased oscillatory power in neural fields in
high-level cortical regions in the 1-100 Hz frequency range (Muthukumaraswamy et al.,
2013). In the present analysis, decreased low frequency power in the .01-.1Hz range was
found and again, these effects were localized to consistent high-level cortical regions. Low
frequency fluctuations in BOLD are known to correlate with neuronal parameters such as
fluctuating gamma power and infraslow fluctuations in local field potentials (Pan et al.,
2013). The slower beta band also shows positive correlations with fMRI fluctuations in key
DMN regions (Laufs et al., 2003), whereas both alpha and beta apparently inhibit large-
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scale cortical BOLD coherence (Tagliazucchi et al., 2012b). Thus, it seems that a primary
action of psilocybin, and likely other psychedelics (Riba et al., 2002), is to cause a gener-
alized desynchrony and loss of oscillatory power in higher level cortical regions - likely via
serotonin 2A receptor mediated excitation of deep-layer pyramidal neurons in these regions
(Muthukumaraswamy et al., 2013)). However, the high amplitude activity detected in the
hippocampi and ACC (Fig. 1) suggests that this desynchronizing effect does not generalize
to these deeper structures.
The frequency domain result was further examined by a separate analysis of the point-
process rate and interval distributions (see Fig. 3). The RSNs which exhibited the most
significant changes correspond to higher brain systems such as the DMN, executive control
and attention networks and not primary sensory and motor networks. This outcome is
consistent with the regional distribution of serotonin 2A receptors (Erritzoe et al., 2009),
the receptors implicated in psilocybin’s psychedelic action (Vollenweider et al., 1998). These
receptors are concentrated in higher level cortical regions (e.g. the highest distribution in
humans is in the PCC (Carhart-Harris et al., 2012b; Erritzoe et al., 2009) and are relatively
less prevalent in the sensori-motor cortex. That the default mode network has consistently
been implicated in the action of psilocybin is also intriguing given its association with self-
reflection (Gusnard et al., 2001) and selfhood more generally (Carhart-Harris and Friston,
2010). It is likely to be relevant therefore that one of the most commonly reported features
of an intense psychedelic experience is a compromised sense of selfhood typically described
as “ego dissolution” or “ego disintegration” (Klee, 1963; Savage, 1955; Carhart-Harris et al.
2014).
A potential limitation of our study arises from the possibility that psilocybin modifies
the coupling between neuronal sources and hemodynamic activity as measured with fMRI
(i.e. the hemodynamic response function). However, we note that there exists no evidence
for this so far and, on the other hand, there exists ample direct electrophysiological evi-
dence showing that psilocybin modifies brain activity in a way compatible with our findings
(Muthukumaraswamy et al., 2013).
Another limitation stems from the limited number of regions included in the definition
of dynamical states. This limited number is required to perform an exhaustive counting of
all possible states, however, differences in the motifs between conditions (Fig. 5) could arise
by direct influence of regions outside the scope of the analysis, which are directly wired to a
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pair of nodes. Future work should address this limitation and attempt to track those regions
to obtain a more complete picture of how dynamical states differ after and before psilocybin
infusion.
Finally, it is important to offer some cautionary notes on the analyses documented in
this paper. Mapping relatively transient dynamical motifs based on resting state fMRI data
is a new and exploratory technique. Thus, further work is required to clarify its functional
meaning. More specifically, given the Zipf-like behavior of the state distribution probability
(Fig. 5B), states that appear rarely (i.e. at the tail of a power law distribution) cannot
be trivially tested using the usual statistical significance, i.e. they do not fit easily into the
standard frequentist framework of t-test statistics, in contrast to well established functional
connectivity analyses that represent an average over prolonged periods of time. Thus, further
mathematical testing and empirical work is required before we can begin to make confident
predictions about the functional relevance of outcomes derived from their application.
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MNI
coordinates
AAL region Hemispheret-value
BOLD variance (after psilocybin >before psilocybin)
(-34, -22, -16) Hippocampus Left 4.51
(26, -22, -16) Hippocampus Right 3.54
(-2, 22, 28) Anterior cingulate Left 3.72
(4, 34, 18) Anterior cingulate Right 3.74
BOLD total spectral power (after psilocybin > before psilo-
cybin)
(32, -14, -13) Hippocampus Right 4.03
(-26, -18, -15) Hippocampus Left 4.39
(-26, 1, 38) Parahippocampal
Gyrus
Left 4.77
(37, -2, -38) Parahippocampal
gyrus
Right 4.55
(7, 27, 17) Anterior cingulate Right 4.02
(-7, 43, -2) Anterior cingulate Left 4.12
Table 1: Regions corresponding to local maxima of statistical significance (provided
they are more than 8 mm apart) for increased cortical BOLD variance and total spectral
power after psilocybin infusion (compared to before psilocybin infusion). Montreal Neuro-
logical Institute (MNI) coordinates and Automatic Anatomical Labeling (AAL) regions are
provided.
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MNI
coordinates
AAL region Hemispheret-
value
BOLD low frequency power (after psilocybin < before psilo-
cybin)
(11, -60, 40) Precuneus Right 4.92
(38, -67, 44) Angular gyrus Right 4.60
(-34, -69, 44) Angular gyrus Left 5.05
(-39, -42, 42) Inferior parietal cortex Left 4.66
(-39, 45, -3) Middle frontal gyrus Left 5.10
(47, 44, -3) Inferior frontal gyrus Right 5.08
(5, 56, -9) Middle frontal gyrus
(orbital)
Right 4.28
BOLD power spectrum scaling exponent α (after psilocybin
< before psilocybin)
(4,-59,33) Precuneus Right 4.86
(53,-61,33) Angular gyrus Right 4.31
(-48,-55,34) Angular gyrus Left 4.20
(-40,-34,60) Postcentral gyrus Left 4.80
(6,-22,60) Paracentral lobule Right 4.79
(50,-30,60) Superior parietal
cortex
Right 5.73
(-41,14,33) Middle frontal gyrus Left 4.32
(52,7,28) Precentral gyrus Right 5.12
(38,41,28) Middle frontal gyrus Right 6.22
(-27,43,28) Middle frontal gyrus Left 5.10
(10,55,-6) Middle frontal gyrus
(orbital)
Right 4.48
Table 2: Regions corresponding to local maxima of statistical significance (more than 8
mm apart) for decreased cortical BOLD low frequency power and power spectrum scaling
exponent after psilocybin infusion (compared to before psilocybin infusion).
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MNI
coordinates
AAL region Hemispheret-value
Point-process rate (after psilocybin > before psilocybin)
(5, -52, 25) Precuneus Right 4.47
(47, -66, 29) Angular gyrus Right 3.99
(-41, -66, 24) Angular gyrus Left 2.84
(-41, 47, -5) Middle frontal
gyrus (orbital)
Left 2.82
(-41, 41, 24) Middle frontal
gyrus
Left 2.97
(35, 40, 24) Middle frontal
gyrus
Right 3.14
Point-process interval (after psilocybin < before psilocybin)
(5, -57, 25) Precuneus Right 4.06
(50, -58, 36) Angular gyrus Right 3.98
(-34, -66, 36) Angular gyrus Left 3.00
(-37, -32, 62) Postcentral gyrus Left 3.35
(41, -39, 62) Paracentral lobule Right 3.18
(-26, -9, 60) Postcentral gyrus Left 3.59
(28, 17, 54) Middle frontal
gyrus
Right 3.72
(-20, 15, 54) Superior frontal
gyrus
Left 2.87
(-22, 59, 12) Superior frontal
gyrus
Left 3.54
(4, 54, 6) Anterior cingulate Right 3.29
Table 3: Regions corresponding to local maxima of statistical significance (provided
they are more than 8 mm apart) for increased cortical point-process rate (PPR) and de-
creased point-process interval (PPI) after psilocybin infusion (compared to before psilocybin
infusion).
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FIG. 1. Psilocybin infusion modifies the temporal variability of BOLD signal in a network compris-
ing anterior cingulate cortex (ACC) and bilateral hippocampus. A) Maps of statistical significance
for variance (σ2) and total spectral power (TP) increases after psilocybin infusion. Results are
shown overlaid separately into an anatomical MNI152 template, overlaid together and also ren-
dered together into a 3D anatomical image. In all cases only clusters surviving a threshold of p
< 0.05, Family Wise Error (FWE) cluster corrected (after passing an uncorrected threshold of p
< 0.005) are shown. B) BOLD Variance time courses (obtained over a 1 min. sliding window)
into the four regions of peak statistical significance defined in Table 1 for the psilocybin and the
placebo infusion. C) Variance of the time course of intra-hippocampal correlations (computed
over a range of non-overlapping window lengths) before and after psilocybin infusion. Results for
placebo infusion are shown as insets (before and after in blue and red, respectively).
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FIG. 2. Psilocybin infusion modifies BOLD spectral content in a distributed fronto-parietal net-
work. A) Maps of statistical significance for decreased low frequency power (LFP) and power
spectrum scaling exponent α after psilocybin infusion. Results are shown overlaid separately into
an anatomical MNI152 template, overlaid together and also rendered together into a 3D anatom-
ical image. Notice that in all cases only clusters surviving a threshold of p < 0.05, FWE cluster
corrected (after passing an uncorrected threshold of p < 0.005) are shown. B) Maps of statistical
significance of increased power point rate (PPR) and decreased point process interval (PPI) after
psilocybin infusion (same renderings and statistical thresholds as in Panel A).
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FIG. 3. BOLD spectral changes after psilocybin infusion are located in higher order brain networks
and leave primary sensory areas unaffected. A) Overlap between statistical significance maps
presented in Fig. 2 and a group of well-established cortical RSN (from (Beckmann et al., 2005))
together with the average overlap obtained after 100 spatial randomizations preserving first order
statistics (image phase shuffling). (*) indicates an empirical p-value smaller than 0.05, Bonferroni
corrected. This p-value is defined as the ratio of instances in which the real maps yield a higher
overlap than the randomized versions. B) Whole brain grey matter average probability distributions
for α, LFP, PPR and PPI, before and after psilocybin infusion. In the inset, the same distributions
are shown before and after the placebo infusion.
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FIG. 4. Entropy of the dynamical functional connectivity states. Illustration of the procedure
to estimate the temporal evolution of the collective states (i.e. all possible 64 motifs) in the net-
work of regions associated with increased temporal variability (bilateral hippocampi and ACC).
After selecting the 4 regions of interest demonstrating enhanced variability after psilocybin infusion
(left and right hippocampus, left and right ACC), the partial correlation between all variables is
computed (including also the mean head displacement time series as a partial regressor). After
thresholding (with p < 0.05, corrected) a series of up to 64 discrete connectivity states are ob-
tained from which the probability distribution can be computed. Finally, from this information,
histograms of states (provided here as an illustration) and their corresponding Shannon’s entropy
(H) can be computed.
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FIG. 5. Dynamical functional connectivity entropy increased after psilocybin infusion. A) Entropy
of connectivity states (H, defined following the procedure outlined in Fig. 4 and computed at
different time window lengths) are plotted for the comparisons placebo before vs. after, psilocybin
before vs. after and psilocybin after vs. placebo after (mean SEM). B) The probability distribu-
tions for the (ranked) dynamical functional connectivity states across all conditions. Histograms
were obtained pooling states across subjects and window sizes. C) First row: five most frequent
connectivity states before the infusion of psilocybin. Second row: Five most frequent states after
the infusion of psilocybin. Third row: States observed only after the infusion of psilocybin, but
absent before the infusion and in the placebo condition. In all cases the lines are used to indicate
a significant transient functional connectivity between two nodes.
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